BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35932066)

  • 1. Healthcare resource utilization and costs in 23-25-year-old women with human papillomavirus (HPV) associated anogenital diseases in Germany - a retrospective analysis of statutory health insurance claims data.
    Reuschenbach M; Mihm S; Wölle R; Schneider KM; Jacob C; Greiner W; Hampl M; Goodman E
    BMC Health Serv Res; 2022 Aug; 22(1):1002. PubMed ID: 35932066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of HPV related anogenital diseases in young women in Germany - an analysis of German statutory health insurance claims data from 2012 to 2017.
    Reuschenbach M; Mihm S; Wölle R; Schneider KM; Jacob C; Braun S; Greiner W; Hampl M
    BMC Infect Dis; 2020 Apr; 20(1):297. PubMed ID: 32321435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare Costs and Resource Use Associated With Cervical Intraepithelial Neoplasia and Cervical Conization: A Retrospective Study of German Statutory Health Insurance Claims Data.
    Stephan AJ; Reuschenbach M; Saxena K; Prabhu VS; Jacob C; Schneider KM; Greiner W; Wölle R; Hampl M
    J Health Econ Outcomes Res; 2022; 9(1):128-139. PubMed ID: 36755814
    [No Abstract]   [Full Text] [Related]  

  • 4. HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis.
    Osmani V; Fett S; Tauscher M; Donnachie E; Schneider A; Klug SJ
    BMC Cancer; 2022 Dec; 22(1):1293. PubMed ID: 36494790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare resource utilization and costs of cardiovascular events in patients with atherosclerotic cardiovascular disease in Germany - results of a claims database study.
    Sidelnikov E; Dornstauder E; Jacob C; Maas C; Pinto L; Leidl R; Ahrens I
    J Med Econ; 2022; 25(1):1199-1206. PubMed ID: 36330899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of sequelae and healthcare resource utilization in the first year of life in infants born with congenital cytomegalovirus (cCMV) infection in Germany: A retrospective statutory health insurance claims database analysis.
    de Lepper M; Stephan AJ; Wölle R; Wang W; Jacob C; Schneider KM; Buxmann H; Goelz R; Hamprecht K; Kummer P; Modrow S; Greiner W; Luzak A; Reuschenbach M
    PLoS One; 2023; 18(11):e0293869. PubMed ID: 37972113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic burden of HPV-related cancers in the US veteran population.
    Saxena K; Dawson RS; Cyhaniuk A; Bello T; Janjan N
    J Med Econ; 2022; 25(1):299-308. PubMed ID: 35156867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic burden of human papillomavirus infection-associated diseases in the Republic of Korea, 2002-2015.
    Ki M; Choi HY; Han M; Oh JK
    Vaccine; 2018 Jul; 36(31):4633-4640. PubMed ID: 29961603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of chronic pain for patients with osteoarthritis in Germany: a retrospective cohort study of claims data.
    Schild M; Müller U; von Schenck U; Prieur S; Miller R
    BMC Musculoskelet Disord; 2021 Mar; 22(1):317. PubMed ID: 33789636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare costs and resource utilization of asthma in Germany: a claims data analysis.
    Jacob C; Bechtel B; Engel S; Kardos P; Linder R; Braun S; Greiner W
    Eur J Health Econ; 2016 Mar; 17(2):195-201. PubMed ID: 25716136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data.
    Thöne K; Horn J; Mikolajczyk R
    BMC Infect Dis; 2017 Aug; 17(1):564. PubMed ID: 28806926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis.
    Krüger K; von Hinüber U; Meier F; Tian H; Böhm K; Jugl SM; Borchert K; Meise D; König C; Braun S
    Rheumatol Int; 2018 Nov; 38(11):2121-2131. PubMed ID: 30094685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of anogenital warts in Germany: a population-based cohort study.
    Kraut AA; Schink T; Schulze-Rath R; Mikolajczyk RT; Garbe E
    BMC Infect Dis; 2010 Dec; 10():360. PubMed ID: 21182757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of CIN2+ diagnoses and conizations in women aged 18-45 years-a retrospective secondary data analysis of German statutory health insurance claims data.
    Reuschenbach M; Stephan AJ; Saxena K; Prabhu VS; Jacob C; Schneider KM; Greiner W; Wölle R; Hampl M
    Arch Gynecol Obstet; 2022 Dec; 306(6):2077-2092. PubMed ID: 35420356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of neural tube defects in Germany.
    Bowles D; Wasiak R; Kissner M; van Nooten F; Engel S; Linder R; Verheyen F; Greiner W
    Public Health; 2014 Mar; 128(3):274-81. PubMed ID: 24559770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The healthcare costs of treating human papillomavirus-related cancers in Norway.
    Hylin H; Thrane H; Pedersen K; Kristiansen IS; Burger EA
    BMC Cancer; 2019 May; 19(1):426. PubMed ID: 31064346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States.
    Jain SS; Li SS; Xie J; Sutton MB; Fine JT; Edelberg JM; Gao W; Spertus JA; Cohen DJ
    J Med Econ; 2021; 24(1):1115-1123. PubMed ID: 34493144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease burden and direct medical costs of incident adult ADHD: A retrospective longitudinal analysis based on German statutory health insurance claims data.
    Libutzki B; May M; Gleitz M; Karus M; Neukirch B; Hartman CA; Reif A
    Eur Psychiatry; 2020 Oct; 63(1):e86. PubMed ID: 32998793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reductions in human papillomavirus-disease resource use and costs with quadrivalent human papillomavirus (types 6, 11, 16, and 18) recombinant vaccination: the FUTURE Study Economic Evaluation.
    Insinga RP; Dasbach EJ; Allen SE; Carides GW; Myers ER
    Value Health; 2008 Dec; 11(7):1022-32. PubMed ID: 18489503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Direct Medical Costs of Diseases Associated with Human Papillomavirus Infection in Manitoba, Canada.
    Righolt CH; Pabla G; Mahmud SM
    Appl Health Econ Health Policy; 2018 Apr; 16(2):195-205. PubMed ID: 29299769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.